Series 06: episode 09
Tune in to the latest episode of the GOLD podcast which sees Isabel sit down for a chat with Wendy Bartie, Senior Vice President and General Manager, US Hematology and Cell Therapy, Bristol Myers Squibb.
In the episode, Wendy discusses her passion for developing life-saving cancer drugs with less toxic side effects. Learn about how far the industry has come, while being guided through the ways in which the sector could still evolve for the benefit of patients.
A little more on GOLD’s guest…
Wendy Bartie is the Senior Vice President and General Manager for US Hematology and Cell Therapy at Bristol Myers Squibb, having joined the company in 2022. A compassionate and strategic leader, her career journey has taken many turns in and out of the pharmaceutical industry – but she has always been determined to help people. She has previously held a range of commercial roles across industry, but prior to her entry to pharma she worked as a Public Defender in Washington, DC, and Bronx, New York.
